Article Text

Download PDFPDF

Original article
Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability
  1. David Hunt1,
  2. Richard J Leventer2,
  3. Cas Simons3,
  4. Ryan Taft3,4,5,
  5. Kathryn J Swoboda6,
  6. Mary Gawne-Cain7,
  7. the DDD study8,
  8. Alex C Magee9,
  9. Peter D Turnpenny10,
  10. Diana Baralle1,11
  1. 1Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK
  2. 2The Royal Children's Hospital Department of Neurology, University of Melbourne Department of Paediatrics and the Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
  3. 3Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia
  4. 4Departments of Integrated Systems Biology and of Pediatrics, School of Medicine and Health Sciences, George Washington University, USA
  5. 5Illumina, Inc., San Diego, California, USA
  6. 6Pediatric Motor Disorders Research Program, Department of Neurology, University of Utah School of Medicine, Salt Lake City, Utah, USA
  7. 7Department of Radiology, Southampton General Hospital, Southampton, UK
  8. 8Wellcome Trust Sanger Institute, Cambridge, UK
  9. 9Genetic Medicine, Belfast City Hospital, Belfast, Northern Ireland
  10. 10Peninsula Clinical Genetics Service, Royal Devon and Exeter Hospital (Heavitree), Exeter, UK
  11. 11Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK
  1. Correspondence to Dr Diana Baralle and David Hunt, Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, SO16 5YA, UK; david.hunt2{at}uhs.nhs.uk, d.baralle{at}soton.ac.uk

Abstract

Background De novo mutations are emerging as an important cause of neurocognitive impairment, and whole exome sequencing of case-parent trios is a powerful way of detecting them. Here, we report the findings in four such trios.

Methods The Deciphering Developmental Disorders study is using whole exome sequencing in family trios to investigate children with severe, sporadic, undiagnosed developmental delay. Three of our patients were ascertained from the first 1133 children to have been investigated through this large-scale study. Case 4 was a phenotypically isolated case recruited into an undiagnosed rare disorders sequencing study.

Results Protein-altering de novo mutations in PURA were identified in four subjects. They include two different frameshifts, one inframe deletion and one missense mutation. PURA encodes Pur-α, a highly conserved multifunctional protein that has an important role in normal postnatal brain development in animal models. The associated human phenotype of de novo heterozygous mutations in this gene is variable, but moderate to severe neurodevelopmental delay and learning disability are common to all. Neonatal hypotonia, early feeding difficulties and seizures, or ‘seizure-like’ movements, were also common.

Additionally, it is suspected that anterior pituitary dysregulation may be within the spectrum of this disorder. Psychomotor developmental outcomes appear variable between patients, and we propose a possible genotype–phenotype correlation, with disruption of Pur repeat III resulting in a more severe phenotype.

Conclusions These findings provide definitive evidence for the role of PURA in causing a variable syndrome of neurodevelopmental delay, learning disability, neonatal hypotonia, feeding difficulties, abnormal movements and epilepsy in humans, and help clarify the role of PURA in the previously described 5q31.3 microdeletion phenotype.

  • Clinical genetics
  • Developmental
  • Epilepsy and seizures
  • Neurology

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.